Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment

Shuai Liu; Yong-Wei Yu

doi:10.4251/wjgo.v17.i1.101581

Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment

World J Gastrointest Oncol. 2025 Jan 15;17(1):101581. doi: 10.4251/wjgo.v17.i1.101581.

Authors

Shuai Liu¹, Yong-Wei Yu²

Affiliations

¹ Department of Cardiology, The First People's Hospital of Jiashan, Jiaxing 314100, Zhejiang Province, China.
² Department of Critical Care Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, China. [email protected].

Abstract

The article concluded that network pharmacology provides new ideas and insights into the molecular mechanism of traditional Chinese medicine (TCM) treatment of cancer. TCM is a new choice and hot spot in the field of cancer treatment. We have also previously published studies on TCM and network pharmacology. In this letter, we summarize the new paradigm of network pharmacology in cancer treatment mechanisms.

Keywords: Cancer; Multicomponent; Multitarget; Network pharmacology; Therapy.